A Safety and Efficacy Evaluation of 3 Bowel Preparations in the Pediatric Population
Public ClinicalTrials.gov record NCT00425594. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00425594
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Braintree Laboratories
- Industry
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Interventions
- HalfLytely and Bisacodyl Tablets - Formulation 1 Drug
- HalfLytely and Bisacodyl Tablets - Formulation 2 Drug
- NuLYTELY Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 16 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2006
- Primary completion
- Apr 30, 2007
- Completion
- Apr 30, 2007
- Last update posted
- Dec 26, 2007
2007
United States locations
- U.S. sites
- 26
- U.S. states
- 21
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35233 | — |
| Not listed | Mobile | Alabama | 36604 | — |
| Not listed | Tuscaloosa | Alabama | 35406 | — |
| Not listed | Phoenix | Arizona | 85016 | — |
| Not listed | Little Rock | Arkansas | 72202 | — |
| Not listed | San Francisco | California | 94143 | — |
| Not listed | Gainesville | Florida | 32610 | — |
| Not listed | Orlando | Florida | 32801 | — |
| Not listed | Park Ridge | Illinois | 60068 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Minneapolis | Minnesota | 55455 | — |
| Not listed | Jackson | Mississippi | 39216 | — |
| Not listed | Omaha | Nebraska | 68198 | — |
| Not listed | Las Vegas | Nevada | 89109 | — |
| Not listed | Morristown | New Jersey | 07962 | — |
| Not listed | Buffalo | New York | 14222 | — |
| Not listed | Cleveland | Ohio | 44106 | — |
| Not listed | Columbus | Ohio | 43205 | — |
| Not listed | Lancaster | Pennsylvania | 17604 | — |
| Not listed | Columbia | South Carolina | 29203 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Temple | Texas | 76508 | — |
| Not listed | Salt Lake City | Utah | 84113 | — |
| Not listed | Burlington | Vermont | 05401 | — |
| Not listed | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00425594, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 26, 2007 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00425594 live on ClinicalTrials.gov.